# Identifying Susceptibility Genes and Shared Genetic Architecture for Longevity and Muscle Weakness

## TL;DR

This study identifies genes linked to longevity and muscle weakness, revealing shared genetic factors that could help promote healthy aging.

## Contribution

The study identifies novel susceptibility genes and shared genetic architecture between longevity and muscle weakness using large-scale GWAS and multi-tissue analysis.

## Key findings

- APOC1 and TOMM40 are associated with longevity, while DYM and TGFA are linked to muscle weakness.
- A significant negative genetic correlation exists between longevity and muscle weakness.
- Pleiotropic genes like PVRL2, PPP1R9A, and the TOMM40/APOE/APOC1 cluster influence both traits.

## Abstract

Longevity and muscle strength are heritable traits, and age‐related muscle weakness is a major contributor to disability in older adults. However, the susceptibility genes and shared genetic mechanisms underlying lifespan and sarcopenia remain unclear. This study aimed to identify genes associated with longevity and muscle weakness and to characterize their shared genetic architecture.

We integrated the largest genome‐wide association studies (GWAS) on longevity (age > 90th: n = 11 262 cases; age > 99th: n = 3484 cases) and muscle weakness (European Working Group on Sarcopenia in Older People (EWGSOP): n = 48 596 cases; Foundation for the National Institutes of Health (FNIH): n = 20 335 cases) with Genotype‐Tissue Expression (GTEx) v8 multi‐tissue expression quantitative trait locus (eQTL) data. Gene–trait associations were evaluated using multi‐tissue and single‐tissue TWAS, and validated using Multi‐marker Analysis of GenoMic Annotation (MAGMA). Mendelian randomization (MR) and colocalization were applied to test causality and shared variants. Cross‐trait genetic correlation was estimated with LDSC, and pleiotropic loci were identified by pleiotropy analysis under the composite null hypothesis (PLACO) followed by Functional Mapping and Annotation (FUMA)/MAGMA annotation.

Across TWAS approaches, APOC1 and TOMM40 were identified as longevity‐associated genes, while DYM and TGFA were susceptibility genes for muscle weakness. In MR analysis, higher expression of APOC1 and TOMM40 increased the odds of longevity (OR > 1, p < 0.05), whereas higher expression of DYM and TGFA reduced the risk of muscle weakness (OR < 1, p < 0.05). Colocalization supported shared causal variants for APOC1 (rs429358, PP.H4 = 0.81) and TOMM40 (rs429358, PP.H4 = 0.85) with longevity (age > 90th survival percentile), and for DYM and TGFA with muscle weakness defined by both EWGSOP and FNIH (PP.H4 > 0.80). A significant negative genetic correlation was observed between longevity and muscle weakness (Rg < 0, p < 0.05). Cross‐trait pleiotropy analysis identified several pleiotropic genes (PVRL2, PPP1R9A, SLC39A8 and the TOMM40/APOE/APOC1 gene cluster) that influence both longevity and muscle weakness.

We identified susceptibility genes for longevity (APOC1, TOMM40) and muscle weakness (DYM, TGFA) and uncovered shared pleiotropic loci linking aging and muscle decline. These findings improve the understanding of the genetic architecture underlying aging‐related phenotypes and provide potential molecular targets for promoting healthy aging and reducing late‐life disability.